![Robert King](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert King
Keine laufenden Positionen mehr
Profil
Robert S.
King worked as a Principal at COR Therapeutics, Inc. from 1993 to 2003, as a Principal at Scios, Inc. from 1991 to 1993, as a Principal at Molecular Devices LLC from 1988 to 1991, and as a VP-Product Development & Manufacturing at Bayhill Therapeutics, Inc. from 2006 to 2011.
He also worked as a Professor at San Jose State University in 1991-1992.
From 2011 to 2017, he was a Senior VP-Product Development & Supply Chain at SciClone Pharmaceuticals LLC, and from 2003 to 2006, he was a VP-Product Development & Manufacturing at Rinat Neuroscience Corp.
Currently, he is the Chief Development Officer at Alector, Inc. since 2017.
Dr. King received his undergraduate degree from the University of Washington and his doctorate from the University of California, Berkeley.
Ehemalige bekannte Positionen von Robert King
| Unternehmen | Position | Ende |
|---|---|---|
| ALECTOR, INC. | Corporate Officer/Principal | 28.10.2022 |
| SCICLONE PHARMACEUTICALS, INC. | Corporate Officer/Principal | 18.01.2017 |
Bayhill Therapeutics, Inc.
 Bayhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics | Corporate Officer/Principal | 01.01.2011 |
Rinat Neuroscience Corp.
 Rinat Neuroscience Corp. BiotechnologyHealth Technology Manufactures & markets drugs for treating neurological diseases | Corporate Officer/Principal | 01.01.2006 |
COR Therapeutics, Inc.
 COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops biopharmaceutical products for acute cardiovascular diseases | Corporate Officer/Principal | 01.01.2003 |
Ausbildung von Robert King
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
74
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
COR Therapeutics, Inc.
COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops biopharmaceutical products for acute cardiovascular diseases | Health Technology |
SciClone Pharmaceuticals LLC
 SciClone Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of cancer and infectious diseases | Health Technology |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals | Health Technology |
Molecular Devices LLC
 Molecular Devices LLC Medical SpecialtiesHealth Technology Develops bio-analytical measurement equipment and software | Health Technology |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Bayhill Therapeutics, Inc.
Bayhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
San Jose State University
 San Jose State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rinat Neuroscience Corp.
Rinat Neuroscience Corp. BiotechnologyHealth Technology Manufactures & markets drugs for treating neurological diseases | Health Technology |
Alector, Inc.
 Alector, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for Alzheimer’s disease and other neurodegenerative disorders | Health Technology |
Wählen Sie MarketScreener 
